Inhibikase Therapeutics, Inc.IKTNASDAQ
LOADING
|||
EV to Sales: Discounted Valuation
Below historical average.
Left:
||||
Enterprise value to sales ratio
Latest
0.00
↓ 100% below average
Average (8y)
39.57
Historical baseline
Range
High:91.32
Low:-6.80
Volatility
248.0%
High variability
| Period | Value | Change |
|---|---|---|
| 2024 | 0.00 | +100.0% |
| 2023 | -6.80 | -114.5% |
| 2022 | 46.73 | +1155.0% |
| 2021 | -4.43 | -105.6% |
| 2020 | 79.77 | -12.7% |
| 2019 | 91.32 | +366.0% |
| 2018 | 19.60 | -60.6% |
| 2017 | 49.79 | -37.9% |
| 2016 | 80.12 | - |